Financial Year |
March 31 2023 |
Monetary Funds |
135,754,127.34 |
Held-for-trading Financial Assets |
4,326,242.00 |
Notes Receivable |
222,514,393.44 |
Accounts Receivable |
531,305,615.71 |
Advances to Suppliers |
9,053,524.98 |
Other Receivables |
30,790,136.29 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
116,735,401.86 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
15,657,008.60 |
Total Current Assets |
1,139,841,115.68 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
18,550,891.61 |
Investment Properties |
-- |
Fixed Assetes |
587,629,380.15 |
Under-construction Projects |
-- |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
38,642,042.81 |
R&D expenses |
-- |
Goodwill |
40,462,004.30 |
Long-Term Deferred and Prepaid Expenses |
28,677,298.90 |
Deferred Income Tax Assets |
35,956,563.63 |
Other Non-Current Assets |
956,188.60 |
Sub-Total of Non-Current Assets |
752,698,796.66 |
Total Assets |
1,892,539,912.34 |
Short-Term Loans |
361,461,500.00 |
Trading Financial liabilities |
-- |
Notes Payable |
118,704,091.21 |
Accounts Payable |
448,311,566.82 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
5,853,259.89 |
Taxes Payable |
20,790,960.98 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
5,448,214.96 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
63,850,000.00 |
Other Current Liabilities |
195,506,758.99 |
Sub-Total of Current Liabilities |
1,229,462,985.44 |
Long-term Loans |
37,390,344.20 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
13,411,552.99 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
51,085,376.36 |
Total Liabilities |
1,280,548,361.80 |
Paid-In Capital(Or Share Stock) |
200,987,600.00 |
Capital Surplus |
273,244,990.52 |
Surplus Reserve |
67,787,751.37 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
90,790,755.82 |
Minority Stockholder's Interest |
34,538,247.60 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
577,453,302.94 |
Owner's Equity(Stockholder's Equity) |
611,991,550.54 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
1,892,539,912.34 |